Cargando…

Three Decades of Interferon-β in Multiple Sclerosis: Can We Repurpose This Information for the Management of SARS-CoV2 Infection?

Detalles Bibliográficos
Autores principales:	Severa, Martina, Farina, Cinthia, Salvetti, Marco, Coccia, Eliana Marina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326001/ https://www.ncbi.nlm.nih.gov/pubmed/32655578 http://dx.doi.org/10.3389/fimmu.2020.01459

Ejemplares similares

Transcriptional dysregulation of Interferome in experimental and human Multiple Sclerosis
por: Srinivasan, Sundararajan, et al.
Publicado: (2017)

Author Correction: Transcriptional dysregulation of Interferome in experimental and human Multiple Sclerosis
por: Srinivasan, Sundararajan, et al.
Publicado: (2018)

Differential Responses of Human Dendritic Cells to Live or Inactivated Staphylococcus aureus: Impact on Cytokine Production and T Helper Expansion
por: Cruciani, Melania, et al.
Publicado: (2019)

The value of Interferon β in multiple sclerosis and novel opportunities for its anti-viral activity: a narrative literature review
por: Bellucci, Gianmarco, et al.
Publicado: (2023)

Thymosins in multiple sclerosis and its experimental models: moving from basic to clinical application
por: Severa, Martina, et al.
Publicado: (2019)

Increased CD8+ T Cell Response to Epstein-Barr Virus Lytic Antigens in the Active Phase of Multiple Sclerosis
por: Angelini, Daniela F., et al.
Publicado: (2013)

Innate Immune Response to SARS-CoV-2 Infection: From Cells to Soluble Mediators
por: Ricci, Daniela, et al.
Publicado: (2021)

Genome-Wide Gene Expression Analysis of Mtb-Infected DC Highlights the Rapamycin-Driven Modulation of Regulatory Cytokines via the mTOR/GSK-3β Axis
por: Etna, Marilena P., et al.
Publicado: (2021)

The Role of Type 1 Interferon in Systemic Sclerosis
por: Wu, Minghua, et al.
Publicado: (2013)

Drug Repurposing for Atopic Dermatitis by Integration of Gene Networking and Genomic Information
por: Adikusuma, Wirawan, et al.
Publicado: (2021)

Human plasmacytoid dendritic cells at the crossroad of type I interferon-regulated B cell differentiation and antiviral response to tick-borne encephalitis virus
por: Etna, Marilena P., et al.
Publicado: (2021)

Eradicating Infectious Disease: Can We and Should We?
por: Russell, Clark Donald
Publicado: (2011)

Loss of Circulating CD8+ CD161(high) T Cells in Primary Progressive Multiple Sclerosis
por: Acquaviva, Massimo, et al.
Publicado: (2019)

Analyzing some concepts of immune regulation of the last three decades: Fostering greater research resilience despite the information overload. A personal view
por: Bretscher, Peter A.
Publicado: (2022)

Rituximab in Multiple Sclerosis: Are We Ready for Regulatory Approval?
por: Brancati, Serena, et al.
Publicado: (2021)

Stage-Specific Role of Interferon-Gamma in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
por: Arellano, Gabriel, et al.
Publicado: (2015)

Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis
por: Xavier, Alexandre, et al.
Publicado: (2023)

A specific anti‐COVID‐19 BNT162b2 vaccine‐induced early innate immune signature positively correlates with the humoral protective response in healthy and multiple sclerosis vaccine recipients
por: Severa, Martina, et al.
Publicado: (2023)

Narcolepsy and H1N1 influenza immunology a decade later: What have we learned?
por: Buonocore, Sofia M., et al.
Publicado: (2022)

Long-Term Consequences of High Titer Neutralizing Antibodies to Interferon-β in Multiple Sclerosis
por: Dunn, Nicky, et al.
Publicado: (2020)

ISG15 protects human Tregs from interferon alpha‐induced contraction in a cell‐intrinsic fashion
por: Pacella, Ilenia, et al.
Publicado: (2020)

Editorial: A Microbial View of Central Nervous System Disorders: Interplay Between Microorganisms, Neuroinflammation and Behaviour
por: Cossu, Davide, et al.
Publicado: (2021)

Can We Repurpose FDA-Approved Alefacept to Diminish the HIV Reservoir?
por: Zaidi, Asifa, et al.
Publicado: (2015)

Repurposing Immunomodulatory Drugs to Combat Tuberculosis
por: Fatima, Samreen, et al.
Publicado: (2021)

Is Dosing of Therapeutic Immunoglobulins Optimal? A Review of a Three-Decade Long Debate in Europe
por: Kerr, Jacqueline, et al.
Publicado: (2014)

Association Between DNA Damage Response, Fibrosis and Type I Interferon Signature in Systemic Sclerosis
por: Vlachogiannis, Nikolaos I., et al.
Publicado: (2020)

The Contribution of Gut Barrier Changes to Multiple Sclerosis Pathophysiology
por: Buscarinu, Maria Chiara, et al.
Publicado: (2019)

Evolution of Interferons and Interferon Receptors
por: Secombes, Chris J., et al.
Publicado: (2017)

Vasculitis Pathogenesis: Can We Talk About Precision Medicine?
por: Ozen, Seza, et al.
Publicado: (2018)

Virus Infections and Host Metabolism—Can We Manage the Interactions?
por: Sumbria, Deepak, et al.
Publicado: (2021)

Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started?
por: Bellucci, Gianmarco, et al.
Publicado: (2021)

Profiling of Canonical and Non-Traditional Cytokine Levels in Interferon-β-Treated Relapsing–Remitting-Multiple Sclerosis Patients
por: D’Angelo, Chiara, et al.
Publicado: (2018)

How can early life adversity still exert an effect decades later? A question of timing, tissues and mechanisms
por: Mposhi, Archibold, et al.
Publicado: (2023)

Lack of Effectiveness of Repurposed Drugs for COVID-19 Treatment
por: Martinez, Miguel Angel
Publicado: (2021)

Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection
por: Severa, Martina, et al.
Publicado: (2021)

Plastic Surgery Diversity through the Decade: Where We Stand and How We Can Improve
por: Hernandez, J. Andres, et al.
Publicado: (2022)

Interferon and interferon-stimulated genes in HBV treatment
por: Li, Qirong, et al.
Publicado: (2022)

Altered Immune Phenotypes and HLA-DQB1 Gene Variation in Multiple Sclerosis Patients Failing Interferon β Treatment
por: Devi-Marulkar, Priyanka, et al.
Publicado: (2021)

Can Antinuclear Antibodies Have a Pathogenic Role in Systemic Sclerosis?
por: Chepy, Aurélien, et al.
Publicado: (2022)

Discovery of All Three Types in Cartilaginous Fishes Enables Phylogenetic Resolution of the Origins and Evolution of Interferons
por: Redmond, Anthony K., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_og3kv612t759tajni6onlud0eb